This CDO Letter to all dental practitioners highlights the launch of NICE guidance about about Antibiotic Prophylaxis Against Infective Endocarditits and reclassification of Midazolam as a controlled drug.
This CDO Letter to all dental practitioners highlights the launch of NICE guidance about about Antibiotic Prophylaxis Against Infective Endocarditits and reclassification of Midazolam as a controlled drug.